(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...
* U.S. FDA- ALERTING PUBLIC TO EARLY DATA THAT SUGGEST POTENTIAL INACCURATE RESULTS FROM USING ABBOTT ID NOW POINT-OF-CARE TEST TO DIAGNOSE COVID-19 * U.S. FDA - ABBOTT'S TEST CAN STILL BE USED AND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback